Associated Papers
Desmoplakin cardiomyopathy: recent updates in natural history and management.
Hoffman-Andrews L et al.
Current Opinion in Cardiology, 2025
Arrhythmogenic left ventricular cardiomyopathy caused by a novel likely pathogenic DSP mutation, p.K1165Rfs*8, in a family with sudden cardiac death.
Azimi A et al.
Bmc Medical Genomics, 2023
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant.
Hoorntje ET et al.
Circulation. Genomic and Precision Medicine, 2023
36580316 (PubMed )
Supplement: EMS158320-supplement-Supplemental_Tables.xlsx › Table_SII
A novel desmoplakin mutation causes dilated cardiomyopathy with palmoplantar keratoderma as an early clinical sign.
Karvonen V et al.
Journal of the European Academy of Dermatology and Venereology : Jeadv, 2022
Desmoplakin and clinical manifestations of desmoplakin cardiomyopathy.
Yuan ZY et al.
Chinese Medical Journal, 2021
DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy.
Heliö K et al.
Bmc Medical Genetics, 2020
Desmoplakin Gene Variants and Risk for Arrhythmogenic Cardiomyopathy.
Favre B et al.
Circulation. Genomic and Precision Medicine, 2018
Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.
Akinrinade O et al.
European Heart Journal, 2015
[Genetic testing in cardiologic diagnostics].
Heliö T et al.
Duodecim; Laaketieteellinen Aikakauskirja, 2010
Select a paper to view details